Credit Capital Investments’s Pfizer PFE Stock Holding History

Credit Capital Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,800	Closed	-$260K	–	41
2024 Q4	$260K	Buy	+9,800	New	+$266K	0.34%	27
2024 Q2	–	Sell	-18,000	Closed	-$500K	–	41
2024 Q1	$500K	Hold	18,000	–	–	0.62%	20
2023 Q4	$518K	Buy	+18,000	New	+$544K	0.72%	21
2023 Q2	–	Sell	-20,000	Closed	-$816K	–	70
2023 Q1	$816K	Buy	+20,000	New	+$864K	1.06%	21
2022 Q4	–	Sell	-5,000	Closed	-$219K	–	72
2022 Q3	$219K	Hold	5,000	–	–	0.29%	52
2022 Q2	$262K	Hold	5,000	–	–	0.3%	52
2022 Q1	$259K	Sell	5,000 -10,721	-68%	-$556K	0.24%	56
2021 Q4	$928K	Buy	+15,721	New	+$779K	0.9%	18

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Capital Investments's PFE Position: Q1 2025 in Review

Credit Capital Investments sold out of Pfizer (PFE) in Q1 2025, closing a stake of 9,800 shares — an estimated $260K sold.

Credit Capital Investments first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $928K in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Credit Capital Investments reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Credit Capital Investments sold 9,800 Pfizer shares in Q1 2025, an estimated $260K.
Credit Capital Investments first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
Credit Capital Investments's Pfizer position peaked at $928K in Q4 2021.
2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Credit Capital Investments's 13F filing for Q1 2025, filed 9 May 2025.